Back to search
Emerging Infectious Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Emerging Infectious Diseases trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Emerging Infectious Diseases trials you may qualify forBackground: Vaccines against SARS-CoV-2, the virus that causes COVID-19, have been highly effective against preventing severe disease. But the protective effec…
Background: \- Increased clinical attention has been paid to the evaluation and management of bioterrorism-related illness (such as anthrax infection) and emer…
This multicenter, randomized, open-label Phase 2 clinical trial evaluates the safety, tolerability, and virologic efficacy of ARN-75039, a novel oral antiviral,…
This multicenter prospective registry aims to establish a biobank of residual biological samples and associated clinical data from hospitalized patients. The re…
Lassa fever (LF) is a viral haemorrhagic fever responsible of 5000 deaths per year in West Africa, with in-hospital mortality at 12%. Transmission to humans occ…
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). The global outbreak of COVID-19 is a major…
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially…
The study aims to evaluate the potential role of ACTH gel in the management of non-infectious uveitis.
This is a prospective, randomized, double-blind, controlled study to determine the effectiveness of Mirasol-treated fresh whole blood (FWB) versus Standard-issu…